Galactan induces macrophage M0 to M1 conversion to combat colon cancer

被引：2
|
作者：
Meng, Yue [1 ]
Yang, Guang [1 ]
Ren, Ai [1 ]
Qu, Yunhe [1 ]
Wang, Xue [1 ]
Mayo, Kevin H. [2 ]
Zhou, Yifa [1 ]
Song, Chengcheng [1 ]
机构：
[1] Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dru, Changchun 130024, Peoples R China
[2] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA
来源：
FOOD SCIENCE AND TECHNOLOGY RESEARCH | 2024年 / 30卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cantharellus cibarius; galactan; macrophages; antitumor effect; TUMOR-ASSOCIATED MACROPHAGES; STRUCTURAL-CHARACTERIZATION; IMMUNOMODULATORY ACTIVITY; CELLS; ACTIVATION; MECHANISMS; PHENOTYPE;
D O I：
10.3136/fstr.FSTR-D-23-00039
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
A 3-O-methylated-galactan WCCP-N-b from Cantharellus cibarius polarizes RAW264.7 macrophages, bone marrow -derived macrophages (BMDMs), and peritoneal macrophages (PEMs) leading to enhanced secretion of cytokine TNF-alpha and subsequent cytotoxic effects on HCT116 and CT26 colon cancer cells. Investigation into the mechanism of action suggests that WCCP-N-b polarizes macrophages by targeting Toll -like receptor 2 and activation of MAPKs and NF -KB signaling pathways. Overall, our results indicate that this linear 3-O-methylated-galactan inhibits colon cancer cells via conversion of M0 to M1 macrophages.
引用
收藏
页码：75 / 82
页数：9
相关论文
共 50 条
  • [21] An M0 macrophage-related prognostic model for hepatocellular carcinoma
    Yiya Zhang
    Ju Zou
    Ruochan Chen
    BMC Cancer, 22
  • [22] 当前货币流通的新特点——M1向M0转移
    陈浩武
    银行与企业, 1989, (05) : 9 - 11
  • [23] ADHERENCE AND SPREADING ARE NOT REQUIRED FOR MACROPHAGE (M0) COMPLEMENT (C) SYNTHESIS
    STRUNK, RC
    KUNKE, K
    MUSSON, RA
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 1200 - 1200
  • [24] An M0 macrophage-related prognostic model for hepatocellular carcinoma
    Zhang, Yiya
    Zou, Ju
    Chen, Ruochan
    BMC CANCER, 2022, 22 (01)
  • [25] Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer
    Deng, Zhenzhen
    Wu, Ning
    Suo, Qishan
    Wang, Jing
    Yue, Yang
    Geng, Lihua
    Zhang, Quanbin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 222 : 562 - 572
  • [26] Silencing of RhoC induces macrophage M1 polarization to inhibit migration and invasion in colon cancer via regulating thePTEN/FOXO1 pathway
    Yang, Bin
    Wang, Lihua
    Tian, Zhiying
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2023, 104 (01) : 33 - 42
  • [27] TUMOR-RELATED INHIBITION OF CHEMOTACTIC MIGRATION (CM) OF MACROPHAGES (M0) IN COLON CANCER
    GIBSON, PR
    HERMANOWICZ, A
    JEWELL, DP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1985, 15 (04): : 546 - 546
  • [28] The role of M1 and M2 macrophage in the cycling phase of breast cancer
    Walker, Nykia D.
    Elias, Michael
    Greco, Steve
    Rameshwar, Pranela
    CANCER RESEARCH, 2016, 76
  • [29] 从货币媒介商品交换角度洞察M0、M1、M2的变化
    易先桥
    中央财经大学学报, 2001, (12) : 31 - 34
  • [30] E0, M0, AND M1 TRANSITIONS AND FRAGMENTATION OF LEVELS IN YB-170 - 2-PHONON 1Y-STATES
    GRIGOREV, EP
    SOVIET JOURNAL OF NUCLEAR PHYSICS-USSR, 1990, 52 (04): : 581 - 585
12345